Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat ...

Subcutaneous therapy could be the future of non–small cell lung cancer (NSCLC) as it would decrease time needed for treatment ...

The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...

The phase 4, open-label AGILE trial compared the safety and efficacy of 60-, 45-, and 30-minute pegloticase infusions vs standard 120-minute protocols.

It’s the last chance for architecture and design lovers to get this retro fix: Charlotte’s modern home tour is taking a final bow. Part of the McClatchy Media Network ...